Dr. Walter Greenleaf is a neuroscientist and a medical technology developer at Stanford University. With over three decades of research and development experience, he is considered a leading authority in digital medicine and medical VR technology.
His current research focuses on developing computer-supported clinical products and applying VR and digital health technology to address problems in behavioral and physical medicine, such as post-traumatic stress, anxiety disorders, depression, stroke, addictions and autism spectrum disorder. He has served as principal investigator for research funded by the NIH and by NASA.
Dr. Greenleaf is currently a visiting scholar at Stanford University’s Virtual Human Interaction Lab, and director of technology strategy at the University of Colorado National Mental Health Innovation Center. He previously served as director of the mind division at Stanford Center on Longevity, where his focus was on age-related changes in cognition.
In addition to his research at Stanford, he is the business, technology and neuroscience advisor to several medical product companies, investment groups, and accelerator / incubator programs.